(firstQuint)Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression.

 This pilot study will recruit 40 patients with Major Depression and a history of at least two failed prior adequate somatic treatments.

 In addition to usual physical work-up, all patients will have extensive thyroid testing, and then will receive standard dose Tranylcypromine (i.

e.

, max.

 60 mg/d).

 Non-remitters will have dose increased to max.

 120 mg/d if tolerated.

 Non-remitters to high dose Tranylcypromine will then have Dextroamphetamine added with frequent blood pressure monitoring to max.

 40 mg/d.

 Non-remitters will have Triiodothyronine added to the Tranylcypromine.

.

 Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression@highlight

This pilot study will assess the efficacy of several sequential pharmacological treatments for patients with Refractory Depression.

